5004 Multicenter phase I clinical trial of daily and weekly everolimus (RAD001) in combination with vinorelbine and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab

2009 ◽  
Vol 7 (2) ◽  
pp. 261 ◽  
Author(s):  
F. Cardoso ◽  
L. Gianni ◽  
G. Jerusalem ◽  
A. Fasolo ◽  
J. Bergh ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Metastatic Breast ◽  
Phase I Clinical Trial ◽  
Multicenter Phase ◽  
Her 2

scholarly journals A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer

2015 ◽  
Vol 4 (7) ◽  
pp. 1051-1059 ◽  
Author(s):  
Pavani Chalasani ◽  
Marilyn Marron ◽  
Denise Roe ◽  
Kathryn Clarke ◽  
Maria Iannone ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Metastatic Breast ◽  
Phase I Clinical Trial
Sign in / Sign up

Export Citation Format

Share Document